In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

72 hr Manufacturer Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi ...

A JAMA Network study found that, despite insulin product price increases, the manufacturers’ share ... how it would cut the list price of its Lantus product by 78%, as well as establishing ...

The insulin manufacturers and the PBMs have blamed ... of three big-selling insulin products in the US – Sanofi's Lantus, Novo Nordisk's Novolog, and Lilly's Humalog – by 2024.

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...

the company launched Lantus, the worlds first and only once a day insulin and in December 2003 ... the date of closing on mutually terms. CBVPL manufactures the anti-rabies vaccine Rabipur ...

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...